Both in Pharmaceuticals
Schrodinger vs Trevi Therapeutics
Over the past year SDGR returned +42.7% and TRVI returned +28.8%; their daily moves had a correlation of 0.18.
SDGR +42.7% TRVI +28.8%Growth of $1, one year, split-adjusted
| Metric | SDGR | TRVI |
|---|---|---|
| Price | $28.52 | $13.99 |
| Market cap | $2.13B | $1.99B |
| Today | +4.93% | +0.90% |
| 1 month | −1.3% | +6.1% |
| 6 months | +119.7% | −1.9% |
| Year to date | +59.5% | +11.7% |
| 1 year | +38.8% | +30.7% |
| Revenue growth (YoY) | +7.5% | — |
| Gross margin | 55.1% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | — |
| Net cash | $413.7M | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | 94.5% | 39.4% |
| Short % of float | 19.8% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).